FDA inspection
Celgene Corporation: FDA inspection ending Jul 18, 2025
FDA inspection 1275526 · Voluntary Action Indicated (VAI) · Summit, NJ
Key facts
| Inspection ID | 1275526 |
|---|---|
| Firm | Celgene Corporation |
| FEI number | 3004991673 |
| Address | 556 Morris Ave |
| City | Summit |
| State | NJ |
| ZIP | 07901 |
| Country | United States |
| Fiscal year | 2025 |
| Inspection end date | Jul 18, 2025 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Human Cellular, Tissue, and Gene Therapies |
| Product type | Biologics |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data